Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML)
Condition(s):Acute Myeloid LeukemiaLast Updated:April 13, 2009Completed
Hide Studies Not Open or Pending
Condition(s):Acute Myeloid LeukemiaLast Updated:April 13, 2009Completed
Condition(s):Congenital Cystic Adenomatoid MalformationLast Updated:March 30, 2015Terminated
Condition(s):Cirrhosis, LiverLast Updated:January 30, 2018Unknown status
Condition(s):Gullian Barre SyndromeLast Updated:September 23, 2014Unknown status
Condition(s):Pregnancy PretermLast Updated:April 26, 2021Completed
Condition(s):Aplastic AnemiaLast Updated:July 21, 2021Completed
Condition(s):Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Burkitt Lymphoma; Diffuse Large Cell Lymphoma; Gray Zone Lymphoma; Lymphoblastic Lymphoma; Anaplastic Large Cell Lymphoma; Hodgkin LymphomaLast Updated:November 9, 2020Completed
Condition(s):Multi-drug Resistant OrganismLast Updated:January 5, 2024Not yet recruiting
Condition(s):Glioblastoma; Glioma, MalignantLast Updated:May 15, 2023Withdrawn
Condition(s):Thalassemia; Iron OverloadLast Updated:September 1, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.